With 4.86 million shares changed hands, the volume of the stock remained heavier than its average volume of 3.04 million shares. The 52-week range on BLND shows that it touched its highest point at $5.53 and its lowest point at $2.08 during that stretch. It currently has a 1-year price target of $5.45. Beta for the stock currently stands at 1.37.
Price Performance and Earnings:
Three-month performance dropped to -16.56% while six-month performance fell -3.08%. The stock gained 32.63% in the past year, while it has lost -10.21% so far this year. A look at the trailing 12-month EPS for BLND yields -0.34 with Next year EPS estimates of 0.06. For the next quarter, that number is 0.01. This implies an EPS growth rate of 82.96% for this year and 189.67% for next year.
Float and Shares Shorts:
At present, 252.13 million BLND shares are outstanding with a float of 204.57 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for BLND since 3 analysts follow the stock currently. There are 2 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 1 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$0.06571724 being high and -$0.07090999 being low. For BLND, this leads to a yearly average estimate of -$0.068152. Based on analyst estimates, the high estimate for the next quarter is $0.02 and the low estimate is $0.0. The average estimate for the next quarter is thus $0.01.
